EURASIAN JOURNAL OF PULMONOLOGY, cilt.21, sa.1, ss.50-56, 2019 (ESCI, TRDizin)
BACKGROUND: Malignant pleural mesothelioma (MPM) is endemic in the population exposed to asbestos and has high health-care cost with a limited life expectancy. The aim of this study is to evaluate the relationship between cost according to treatment type and prognosis in MPM.